CANCER PREVENTION PHARMACEUTICALS, INC. SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENTSeries a-2 Preferred Stock Purchase Agreement • September 4th, 2015 • Cancer Prevention Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Series A-2 Preferred Stock Purchase Agreement (this “Agreement”) dated as of September __, 2012 is between Cancer Prevention Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the persons (each, an “Investor” and collectively, the “Investors”) listed on the Schedule of Investors attached as Exhibit A (the “Schedule of Investors”).
EX-10.9 2 dex109.htm SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENT EPAM SYSTEMS, INC. SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENTSeries a-2 Preferred Stock Purchase Agreement • May 5th, 2020 • New York
THIS SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”) is entered into as of February 11, 2008 between EPAM Systems, Inc., a Delaware corporation (the “Company”), and the undersigned purchasers (each, a “Purchaser” and, collectively, the “Purchasers”) set forth on the Schedule of Purchasers attached hereto as Schedule 1 (the “Schedule of Purchasers”).
SEQLL INC. FIRST AMENDMENT TO SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENTSeries a-2 Preferred Stock Purchase Agreement • April 23rd, 2019 • SeqLL, Inc. • Laboratory analytical instruments • Delaware
This First Amendment to Series A-2 Preferred Stock Purchase Agreement (this “Amendment”) is dated as of January 12, 2018, and is made by and among SeqLL Inc., a Delaware corporation (the “Company”), and certain purchasers of shares of Series A-2 Preferred Stock of the Company (the “Purchasers”) pursuant to that certain Series A-2 Preferred Stock Purchase Agreement, dated February 19, 2016, by and among the Company and the Purchasers (as amended to date, the “Agreement”). Capitalized terms not otherwise defined herein shall have the meaning given them in the Agreement.
ACIEX THERAPEUTICS, INC. SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENT August 1, 2011Series a-2 Preferred Stock Purchase Agreement • November 9th, 2011 • Akorn Inc • Pharmaceutical preparations • Delaware
This Series A-2 Preferred Stock Purchase Agreement (this “Agreement”) is made as of the 1st day of August, 2011 by and between Aciex Therapeutics, Inc., a Delaware corporation (the “Company”), and Akorn, Inc., a Louisiana corporation (the “Purchaser”).
OCCAM NETWORKS, INC. SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENT November 19, 2003Series a-2 Preferred Stock Purchase Agreement • November 21st, 2003 • Occam Networks Inc/De • Computer communications equipment • California
This Series A-2 Preferred Stock Purchase Agreement (this ”Agreement”) is made as of November 19, 2003, by and among Occam Networks, Inc., a Delaware corporation (the ”Company”), and the persons and entities (each, an “Investor” and collectively, the “Investors”) listed on the Schedule of Investors attached as Exhibit A.
Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. [***] indicates that information has been redacted. RUBRYC THERAPEUTICS, INC....Series a-2 Preferred Stock Purchase Agreement • August 27th, 2021 • iBio, Inc. • Pharmaceutical preparations • Delaware
THIS SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”), is made as of August 23, 2021, by and among RubrYc Therapeutics, Inc., a Delaware corporation (the “Company”), and the investors listed on Exhibit A attached to this Agreement (each a “Purchaser” and together the “Purchasers”).
SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENT by and between WILLIS LEASE FINANCE CORPORATION and DEVELOPMENT BANK OF JAPAN INC. Dated as of September 22, 2017Series a-2 Preferred Stock Purchase Agreement • September 28th, 2017 • Willis Lease Finance Corp • Wholesale-machinery, equipment & supplies • Delaware
THIS SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”), is made as of the 22nd day of September, 2017 by and between Willis Lease Finance Corporation, a Delaware corporation (the “Company”), and Development Bank of Japan Inc., a Japanese corporation (the “Investor”).
RECITALSSeries a-2 Preferred Stock Purchase Agreement • March 12th, 2004 • Occam Networks Inc/De • Computer communications equipment • California
Hylete, INC. SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENTSeries a-2 Preferred Stock Purchase Agreement • November 21st, 2018 • Hylete, Inc. • Apparel & other finishd prods of fabrics & similar matl • California
OCCAM NETWORKS, INC. SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENT First Closing: January 7, 2005Series a-2 Preferred Stock Purchase Agreement • January 13th, 2005 • Occam Networks Inc/De • Computer communications equipment • California
This Series A-2 Preferred Stock Purchase Agreement (this “Agreement”) is made as of January 7, 2005, by and among Occam Networks, Inc., a Delaware corporation (the “Company”), and the persons and entities (each, an “Investor” and collectively, the “Investors”) listed on the Schedule of Investors attached as Exhibit A.
AMENDMENT NO. 2 TO SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENTSeries a-2 Preferred Stock Purchase Agreement • April 9th, 2004 • Occam Networks Inc/De • Computer communications equipment • California
This AMENDMENT NO. 2 (the “Second Amendment”) to the Series A-2 Preferred Stock Purchase Agreement dated as of November 19, 2003 (the “Purchase Agreement”) is made and entered into as of April 1, 2004 by and among Occam Networks, Inc., a California corporation (the “Company”); and each of the Investors (as defined in the Purchase Agreement). Capitalized terms used and not otherwise defined in this Second Amendment shall have the meanings ascribed to them in the Purchase Agreement.
AMENDMENT NO. 1 TO SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENTSeries a-2 Preferred Stock Purchase Agreement • March 24th, 2005 • Occam Networks Inc/De • Computer communications equipment • California
THIS AMENDMENT NO. 1 (this “Amendment”) to that certain Series A-2 Preferred Stock Purchase Agreement dated as of January 7, 2005 (the “Purchase Agreement”), by and among Occam Networks, Inc., a Delaware corporation (the “Company”), and the persons and entities listed on the Schedule of Investors attached thereto as Exhibits A-1 and A-2 is entered into this 23rd day of March, 2005. Capitalized terms not defined herein have the meanings set forth in the Purchase Agreement.
SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENTSeries a-2 Preferred Stock Purchase Agreement • July 24th, 2020 • Delaware
AGREEMENT (the “Amendment”) is entered into as of , 2017 (the “Effective Date”) by and among Ixcela, Inc., a Delaware corporation (the “Company”), and the Purchasers listed on the signature page hereto, which Purchasers are the holders of a majority of Shares (as defined below) issued pursuant to the Purchase Agreement (as defined below) outstanding as of the Effective Date.
ACIEX THERAPEUTICS, INC. AMENDMENT NO. 1 TO SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENTSeries a-2 Preferred Stock Purchase Agreement • November 9th, 2011 • Akorn Inc • Pharmaceutical preparations • Delaware
This AMENDMENT NO. 1 TO SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENT (“Amendment”), dated as of September __, 2011, amends that certain Series A-2 Preferred Stock Purchase Agreement (the “Purchase Agreement”), dated as of August 1, 2011, by and between Aciex Therapeutics, Inc. (the “Company”) and Akorn, Inc. (the “Purchaser”). Capitalized terms used and not defined herein shall have the meanings set forth in the Purchase Agreement.
SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENTSeries a-2 Preferred Stock Purchase Agreement • September 27th, 2022 • Delaware
